Skip to main content
. Author manuscript; available in PMC: 2021 May 2.
Published in final edited form as: Crit Rev Clin Lab Sci. 2019 Nov 2;57(3):161–180. doi: 10.1080/10408363.2019.1678568

Figure 2.

Figure 2.

Relationship between PK, PD, and pharmacogenetics. Once a drug is administered, PK affects the concentration of that drug that reaches the bloodstream. The amount of drug that ends up at the desired site of action is largely dependent on the distribution component of PD. Both PK and PD can be altered by pharmacogenetics variants, ultimately resulting in changes in concentration and desired effect. Modified from [105].